| pubmed-article:2573366 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2573366 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
| pubmed-article:2573366 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:2573366 | lifeskim:mentions | umls-concept:C0022663 | lld:lifeskim |
| pubmed-article:2573366 | lifeskim:mentions | umls-concept:C0019010 | lld:lifeskim |
| pubmed-article:2573366 | lifeskim:mentions | umls-concept:C0205307 | lld:lifeskim |
| pubmed-article:2573366 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:2573366 | lifeskim:mentions | umls-concept:C0076166 | lld:lifeskim |
| pubmed-article:2573366 | pubmed:issue | 11 Pt 2 | lld:pubmed |
| pubmed-article:2573366 | pubmed:dateCreated | 1990-1-4 | lld:pubmed |
| pubmed-article:2573366 | pubmed:abstractText | Administration of beta-blockers is frequently associated with decreases in both renal plasma flow and glomerular filtration rate (GFR). Tertatolol, a new non-selective beta-blocker, has demonstrated similar systemic effects to other conventional beta-blockers, but tertatolol produces increases in both renal plasma flow and glomerular filtration rate. To evaluate the renal hemodynamic mechanism responsible for the increase in GFR, micropuncture experiments were performed in normal Munich-Wistar rats. Intravenous injection of tertatolol produced a significant increase in GFR and urinary sodium excretion in spite of a decrease in systemic blood pressure. Single nephron glomerular filtration rate was significantly increased due to an increase in single nephron plasma flow related to parallel afferent and efferent arteriolar dilatation. No significant changes in glomerular hydrostatic pressure, transcapillary hydrostatic pressure gradient or the ultrafiltration coefficient were demonstrated with tertatolol. The capacity of tertatolol to increase glomerular filtration rate and to promote sodium excretion without modifying critical glomerular pressures makes this agent a highly attractive antihypertensive drug. | lld:pubmed |
| pubmed-article:2573366 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2573366 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2573366 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2573366 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2573366 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2573366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2573366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2573366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2573366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2573366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2573366 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2573366 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:2573366 | pubmed:issn | 0895-7061 | lld:pubmed |
| pubmed-article:2573366 | pubmed:author | pubmed-author:BlantzR CRC | lld:pubmed |
| pubmed-article:2573366 | pubmed:author | pubmed-author:PetersonO WOW | lld:pubmed |
| pubmed-article:2573366 | pubmed:author | pubmed-author:ProstJ FJF | lld:pubmed |
| pubmed-article:2573366 | pubmed:author | pubmed-author:GabbaiF BFB | lld:pubmed |
| pubmed-article:2573366 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2573366 | pubmed:volume | 2 | lld:pubmed |
| pubmed-article:2573366 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2573366 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2573366 | pubmed:pagination | 213S-218S | lld:pubmed |
| pubmed-article:2573366 | pubmed:dateRevised | 2009-2-24 | lld:pubmed |
| pubmed-article:2573366 | pubmed:meshHeading | pubmed-meshheading:2573366-... | lld:pubmed |
| pubmed-article:2573366 | pubmed:meshHeading | pubmed-meshheading:2573366-... | lld:pubmed |
| pubmed-article:2573366 | pubmed:meshHeading | pubmed-meshheading:2573366-... | lld:pubmed |
| pubmed-article:2573366 | pubmed:meshHeading | pubmed-meshheading:2573366-... | lld:pubmed |
| pubmed-article:2573366 | pubmed:meshHeading | pubmed-meshheading:2573366-... | lld:pubmed |
| pubmed-article:2573366 | pubmed:meshHeading | pubmed-meshheading:2573366-... | lld:pubmed |
| pubmed-article:2573366 | pubmed:meshHeading | pubmed-meshheading:2573366-... | lld:pubmed |
| pubmed-article:2573366 | pubmed:meshHeading | pubmed-meshheading:2573366-... | lld:pubmed |
| pubmed-article:2573366 | pubmed:meshHeading | pubmed-meshheading:2573366-... | lld:pubmed |
| pubmed-article:2573366 | pubmed:meshHeading | pubmed-meshheading:2573366-... | lld:pubmed |
| pubmed-article:2573366 | pubmed:meshHeading | pubmed-meshheading:2573366-... | lld:pubmed |
| pubmed-article:2573366 | pubmed:meshHeading | pubmed-meshheading:2573366-... | lld:pubmed |
| pubmed-article:2573366 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2573366 | pubmed:articleTitle | Effect of tertatolol on glomerular hemodynamics in the normal Munich-Wistar rat. | lld:pubmed |
| pubmed-article:2573366 | pubmed:affiliation | Department of Medicine, University of California, San Diego School of Medicine, La Jolla. | lld:pubmed |
| pubmed-article:2573366 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2573366 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
